Interleukin‐1α expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: Important pathogenic features independent of inflammatory cell clusters in muscle tissue
Open Access
- 5 April 2002
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (4) , 1044-1055
Abstract
Objective: To address the hypothesis that endothelial cells and/or muscle fibers are primary targets in the disease process by analysis of muscle tissue from patients with polymyositis (PM) and dermatomyositis (DM).Methods: We included patients with laboratory signs and clinical symptoms typical of myositis, but without detectable infiltration of clusters of inflammatory cells in their muscle biopsy samples. An immunohistochemical technique was applied to identify CD3, CD68, lymphocyte function–associated antigen 1α, CD11b, very late activation antigen 4, endothelium 4, interleukin‐1α (IL‐1α), intercellular adhesion molecule 1, vascular cell adhesion molecule 1, IgG, IgM, IgA, and HLA–A/B/C in muscle tissue. Fiber type was defined by ATPase staining.Results: IL‐1α expression was detected in endothelial cells of capillaries to a greater extent in patients than in controls, and class I major histocompatibility complex (MHC) expression was significantly increased in muscle fibers. We also observed that class I MHC expression was mainly confined to type II muscle fibers.Conclusion: Our findings imply that defined molecular changes of blood vessels and muscle fibers are both independent of adjacent inflammatory infiltrates and could thus be primary events in the development of myositis. Moreover, both IL‐1α and class I MHC molecules might be important for the development of clinical symptoms in PM and DM patients.Keywords
This publication has 36 references indexed in Scilit:
- Decreased expression of interleukin-1α, interleukin-1β, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositisArthritis & Rheumatism, 2000
- New developments in the role of cytokines and chemokines in inflammatory myopathiesCurrent Opinion in Rheumatology, 1998
- Inflammatory myopathies: Issues in diagnosis and managementArthritis & Rheumatism, 1997
- Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathiesArthritis & Rheumatism, 1997
- Immunopathogenesis of inflammatory myopathiesAnnals of Neurology, 1995
- Expression of Cell Adhesion Molecules in Inflammatory Myopathies and Duchenne DystrophyJournal of Neuropathology & Experimental Neurology, 1994
- Microvascular changes in skeletal muscle in idiopathic inflammatory myopathyHuman Pathology, 1992
- Microvascular changes in early and advanced dermatomyositis: A quantitative studyAnnals of Neurology, 1990
- Current Concepts in the Idiopathic Inflammatory Myopathies: Polymyositis, Dermatomyositis, and Related DisordersAnnals of Internal Medicine, 1989
- Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cellsAnnals of Neurology, 1984